HomePLRX • NASDAQ
add
Pliant Therapeutics Inc
Previous close
$15.61
Day range
$15.24 - $15.87
Year range
$11.21 - $24.74
Market cap
921.18M USD
Avg Volume
389.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 52.39M | 20.64% |
Net income | -46.96M | -25.05% |
Net profit margin | — | — |
Earnings per share | -0.78 | -16.42% |
EBITDA | -51.88M | -24.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 482.39M | -16.44% |
Total assets | 521.60M | -12.76% |
Total liabilities | 84.27M | 134.35% |
Total equity | 437.33M | — |
Shares outstanding | 60.33M | — |
Price to book | 2.15 | — |
Return on assets | -25.34% | — |
Return on capital | -26.81% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -46.96M | -25.05% |
Cash from operations | -30.27M | 0.02% |
Cash from investing | 59.55M | 134.18% |
Cash from financing | 21.79M | -92.03% |
Net change in cash | 51.06M | -25.83% |
Free cash flow | -18.18M | -8.43% |
About
Founded
2015
Headquarters
Website
Employees
158